There is a risk that ICSI may increase the transmission of mtDNA diseases to children born after this technique. Knowledge of the fate and transmission of paternal mitochondrial DNA is important since mutations in mitochondrial DNA have been described in oligozoospermic males. We have used an adaptation of solid phase mini-sequencing to exclude the presence of levels of paternal mtDNA >0.001% in ICSI families. This method is more sensitive than those used in previous studies and is sufficient to detect the likely paternal contribution (∼0.1-0.5% from simple calculations of expected dilution during fertilization). Using this method, we were able to detect concentrations as low as 0.001% paternal mtDNA in a maternal mtDNA background. No paternal mtDNA was detected in the embryonic (blood or buccal swabs) tissue of children born after ICSI nor in extraembryonic tissue (placenta or umbilical cord). In conclusion, we did not detect paternal mtDNA in blood, buccal swabs, placenta or umbilical cord of children born after ICSI. We have found no evidence that ICSI increases the risk of paternal transmission of mtDNA and hence of mtDNA disorders.
Introduction
It has been assumed that human mitochondrial DNA (mtDNA) is essentially maternally inherited because sperm mtDNA is selectively destroyed after fertilization (Kaneda et al., 1995) . mtDNA mutants can cause severe diseases in humans (Suomalainen, 1997) and cytoplasmic male sterility (CMS, or non-functional pollen) in higher plants (Young and Hanson, 1987) . Hence mitochondrial dysfunction might also be a feature of human male infertility and mutations in mtDNA have been described in subfertile men (Folgero et al., 1993) .
ICSI has transformed the treatment of male infertility but has theoretical genetic risks. ICSI is an increasingly common treatment for infertility, particularly for men with low or absent sperm counts, or immotile sperm. Sperm are collected from ejaculates, or are harvested by PESA (percutaneous epididymal sperm aspiration) or by aspiration/extraction from the testis (TESA, TESE), and a single sperm is injected into an oocyte. In some centres it is used in preference to simple IVF due to its high success rate. One of the reasons for this success is that it bypasses a number of stages of natural fertilization, including zona pellucida penetration and gamete membrane fusion. There are two major concerns. First, that this may also bypass the supposed mechanism (Kaneda et al., 1995) by which paternal mtDNA is removed from the embryo. mtDNA is more likely to suffer free radical-induced damage than nuclear DNA (Yakes and Van Houten, 1997) , so sperm that have undergone oxidative stress could deliver defective mtDNA to an oocyte even though the sperm nucleus is unaffected. Similarly, as sperm carry more mtDNA deletions than oocytes (Reynier et al., 1998) , there is more potential for passing
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© European Society of Human Reproduction and Embryology on mtDNA disease. Second, ICSI presumably removes much of the selection against genes for male infertility (Silber et al., 1998; Page et al., 1999; Phillipson et al., 2000) . This is particularly important in the case of mtDNA because it has been implicated in human male infertility (Folgero et al., 1993; Ruiz-Pesini et al., 2000a,b) . Transmission of mutated paternal mtDNA via ICSI may thus lead to progressive and debilitating disorders.
In normal individuals, the vast majority of mtDNA are identical (homoplasmy), but in mtDNA disease, heteroplasmy (coexistance of mutant and normal mtDNA) is common. Because mtDNA with a point mutation may become homoplasmic and hence the mtDNA could found a maternal lineage within a single generation-the socalled bottleneck (Blok et al., 1997) -small quantities of exogenous mtDNA could have a profound effect. The paternal component would comprise up to 0.5% of the 100 000 mtDNA in each oocyte, but could potentially be amplified to a significant population in the progeny because of these unique genetic effects.
Previous studies have not detected a paternal contribution to the mtDNA in offspring of ICSI pregnancies at levels Ͼ0.01-1% (Houshmand et al., 1997; Torroni et al., 1998; Danan et al., 1999) . However, these studies did not investigate extra-embryonic tissue. This is important, because mtDNA may have an uneven distribution between different tissues in a single individual (Poulton et al., 1995) . Differences in the ratio between wild type and mutant DNA in different tissues, so called heteroplasmy, is well known for pathogenic mtDNA in mitochondrial diseases (Taylor et al., 1997) . If paternal mtDNA did survive after ICSI and replicate during development, this Figure 1 . Principles of solid phase mini-sequencing, utilizing a G→A base change. The region of interest is amplified by PCR using a biotinylated reverse primer, to allow immobilization of the product on a streptavidincoated plate. Excess reagents are removed and the plate is washed. A single round of PCR is performed using a detection primer corresponding to the sequence immediately upstream of the polymorphism and a radiolabelled dNTP, corresponding to either the paternal or maternal sequence. This allows extension by 1 bp if the dNTP matches the sequence present. Separate reactions are performed to detect the two different sequences. Excess reagents are removed and the plate is washed. The primer is then removed by denaturation and electrophoresed on 8% acrylamide Trisborate-EDTA buffer/urea gels. The gel is dried and exposed to storage phosphor screens to detect radiolabelled primer. might mean that paternal mtDNA could be enriched in some tissues and diluted in others.
We have adapted solid phase mini-sequencing, a highly sensitive method for quantifying mixed populations of mtDNA, to exclude levels of as low as 0.001% paternal mtDNA. In this study, the origin of mtDNA was investigated in placenta, umbilical cord, blood and buccal swabs of children born following ICSI.
Materials and methods
DNA was extracted by standard methods (Sambrook et al., 1989) . For ICSI parent-child pairs, we obtained mtDNA sequence data for a 400 bp region of the first hypervariable region of the large non-coding region. M13 tagged primers, TGTAAAACGACGGCCAGTCTCAAATGGGCCTGT-CCTTG (forward primer) and CAGGAAACAGCTATGACCTTGATTTC-ACGGAGGATGGTG (reverse primer), were used to PCR amplify the region from nucleotides 15 875 to 16 421 using ABgene PCR Mastermix with 1.5 mmol/l MgCl 2 . Five pmol of primer and 1 µl of DNA (at~50 ng/µl) were used in a 50 µl reaction volume. Amplifications were performed for 40 cycles (1 min each at 94°C, 55°C, 72°C, with an initial denaturing step of 4 min at 94°C and a final extension of 10 min at 72°C. Sequencing reactions used standard ABI Bigdye terminator chemistry and conditions and primers corresponding to the M13 tags (TGTAAAACGACGGCCAGT and CAGG-AAACAGCTATGACC). Reactions were run on an ABI 377XL Prism DNA Sequencer. Polymorphic sequence variants that could be used to distinguish between paternal and maternal mtDNA were identified. This was followed by solid phase mini-sequencing (Suomalainen and Syvanen, 1996) . This is a highly sensitive method, involving sequence-specific incorporation of radionucleotides in a primer extension assay (see Figure 1) . A forward primer AAGTAGCATCCGTACTAT and a 5Ј biotinylated reverse primer were used to PCR amplify the region of mtDNA from nucleotides 15 800 to 16 417 using the same conditions as for the PCR for sequencing, except that an annealing temperature of 50°C was used. 10 µl PCR product was added to 15 µl binding buffer (TE pH 8.0 with 2 mol/l NaCl) and bound to the wells of a streptavidin-coated 96-well plate (ABgene) for 1 h. Plates were washed three times with washing buffer (TE pH 8.0 with 1 mol/l NaCl). 50 µl of a PCR mix was added, followed by denaturation for 5 min at 94°C and extension at 50°C for 10 min. The PCR mix contained 1.5 mmol/l MgCl 2 , 0.1 IU of Taq Polymerase, 5 pmol of a primer corresponding to the 18 bp upstream Parental DNA was extracted from blood or buccal swabs, and the first hypervariable region of the large non-coding region of mtDNA was amplified by PCR and sequenced using Bigdye cycle sequencing. The polymorphic changes identified were used to design detection primers encompassing the 18 bp upstream of the polymorphism.
of the polymorphic base change of interest and 27 nmol of a single 32 Pradiolabelled dNTP corresponding to either the maternal or the paternal sequence. The plate was washed three times with washing buffer and 30 µl denaturing buffer was added [80% formamide, 10 mmol/l EDTA (pH 8.0) 1 mg/ml xylene cyanol, 1 mg/ml bromophenol blue]. The plate was heated to 95°C for 5 min and transferred to ice. Samples of 4 µl were loaded onto 1 mm thick, 8 cmϫ8 cm 8% acrylamide 1ϫTris-borate-EDTA buffer/7 mol/l urea gels and electrophoresed for 45 min at 180 V. Gels were dried under heat and vacuum and exposed to storage phosphor screens for quantification of radioactivity in a phoshorimager.
Results
Eleven ICSI pregnancies were investigated. These ICSI pregnancies were all derived from ejaculated sperm. In all cases, the fathers suffered from severe oligozoospermia. DNA was extracted from placenta (n ϭ 3), buccal swabs (n ϭ 3) or placenta, umbilical cord and blood (n ϭ 5). Parental DNA was extracted from either blood or buccal swabs. Sequence analysis using Bigdye cycle sequencing demonstrated that there were usable mtDNA differences in all cases (Table I) . These were used to design sets of PCR primers that allowed the detection of the parent-specific sequences (Figure 1 ). Initially we obtained a notable background signal using solid phase minisequencing, and this was not abolished by washing or minor alterations in the conditions. Subsequent investigation of the cause of the background revealed the presence of short PCR products which were not specific to either parent. However, acrylamide gel electrophoresis of the products of the primer extension (Figure 2 ) revealed that there was a high degree of specificity for the product of appropriate length. All detection primers were tested on mixes of paternal and maternal DNA samples mixed at ratios lower than those expected if paternal mtDNA was present in an embryo (i.e. Ͻ0.01%) to confirm that we would detect it if present. Using this method we were able to detect Ͻ0.001% paternal mtDNA after mixing paternal mtDNA into a maternal mtDNA background (Figure 3) . No paternal mtDNA was detected in any of the ICSI samples. As controls, buccal swab samples from eight IVF families with differing paternal/maternal polymorphisms at nucleotides 16 069 (two families), 16 189 (two families), 16 192, 16 224 and 16 362 (two families) were also analysed and no evidence of paternal mtDNA transmission was found.
Discussion
In normal individuals there is generally a single population of identical mtDNA (homoplasmy). Two mechanisms probably underlie this. On To determine the sensitivity of the method, paternal mtDNA was mixed with maternal mtDNA in ratios encompassing those expected in an embryo in which paternal mtDNA was present. The radiolabelled primer representing the paternal sequence was detected by phosphorimaging after solid phase mini-sequencing as described in Materials and methods. No paternal sequence was detected in a water negative control or 100% maternal mtDNA but was detectable when paternal mtDNA was mixed with maternal mtDNA down to a concentration of 0.0001%.
the maternal side, the so-called mtDNA bottleneck during oogenesis ensures that all of the 100 000 mtDNA in a normal oocyte arise from a small number or a single mtDNA founder. On the paternal side, the mitochondrial bottleneck has an anatomical basis, and it is arguable that the minute contribution of sperm mtDNA to the zygote must be fully functional if it is to win the race against other sperm to the oocyte. While it is commonly held that mtDNA is exclusively maternally inherited, paternal mtDNA has been detected in abnormal human embryos at the blastocyst stage (St John et al., 2000) and mouse studies have shown that paternal mitochondria may persist in the zygote for several days (Cummins et al., 1999) . Furthermore, ICSI alters both the time course of early development of the zygote (Tesarik et al., 1994) and potentially the dose of the paternal contribution to mtDNA. The use of immature sperm types 1048 including epididymal and testicular sperm might increase the risk of paternal mtDNA inheritance. Between meiosis and the end of spermatogenesis there is an 8-10-fold reduction in mtDNA copy number per cell (Hecht et al., 1984) , reducing the number of paternal mtDNA molecules available for potential transmission in mature spermatocytes. Sperm mitochondria are ubiquitinylated during spermatogenesis. This ubiquitinylation is masked during the epididymal passage but unmasked and amplified after fertilization, targeting the sperm mitochondria for destruction in the 2-4-cell embryo (Sutovsky et al., 2000) . This process appears to be dependent on species-specific recognition, raising the possibility that in abnormal sperm development or immature sperm this recognition/destruction system may be defective. Our adaptation of solid phase mini-sequencing has improved its sensitivity and enabled us to exclude levels of as low as 0.001% paternal mtDNA in both embryonic and extra-embryonic tissues in 11 children born following ICSI using ejaculated sperm. In fertilized oocytes, the expected level of paternal mtDNA would be 0.1-0.5%. Thus our results argue against a possible compartmentalization of the injected sperm tail in the fertilized oocyte. Such a compartmentalization could theoretically lead to relatively high levels of paternal mtDNA in either embryonic or extra-embryonic tissues. Our findings also lend further support to the results of other groups who have obtained negative results in embryonic tissues, using less sensitive techniques (Houshmand et al., 1997; Torroni et al., 1998; Danan et al., 1999) .
Investigating the potential for paternal inheritance of mtDNA is important for two reasons. First, ICSI presumably eliminates the selection pressures that normally maintain genetic fitness (Silber et al., 1998; Phillipson et al., 2000) . By eliminating the anatomical basis of the mitochondrial bottleneck, ICSI may select for mtDNA mutations causing male infertility. Second, population geneticists routinely use mtDNA haplotypes to trace population migrations and infer divergence times based on mtDNA diversity. These studies assume that mtDNA does not recombine. However, recent reanalyses suggest that this critical assumption may be incorrect (Eyre-Walker et al., 1999) . The proposal that mtDNA might recombine requires the mixing of mtDNA from two disparate lineages. This infers coexistence of paternal and maternal mtDNA in a single cell.
In conclusion, we did not detect paternal mtDNA in blood, buccal swabs, placenta or umbilical cord of children born after ICSI. We have found no evidence that ICSI increases the risk of paternal transmission of mtDNA and hence, of mtDNA disorders.
